about
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsNew therapeutic options for HCV infection in the monoclonal antibody eraHepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral GenotypesMolecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.HCV E2 core structures and mAbs: something is still missing.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy.Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge.A Biologically-validated HCV E1E2 Heterodimer Structural Model.Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference.Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin.Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study.Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal VaccinesNext Generation Vaccines for Infectious Diseases.Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin AntigensPreexisting subtype immunodominance shapes memory B cell recall response to influenza vaccinationA Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against HemagglutininAn Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses
P50
Q24289014-2D9D3418-D232-4746-BC0E-23FB370D21B5Q26864416-B79A3415-DA09-40C8-8ED3-75A499795A95Q27490450-71144803-BD3E-4DF0-8E9A-8CDD45A51FA0Q30385304-06FDFF66-9B01-4A54-AB33-33414ED7A18DQ34355733-4FE59B12-F83F-4D1E-A735-5D8E7282C35BQ36682313-68A0D8A9-624C-42C9-A440-38EC412F2D90Q38244787-BEDD368B-CC94-4474-9FCE-F5B4CD731A6DQ38417056-E5D70774-34AC-4472-9DBB-8124D5356F73Q39178773-94452EC6-5A50-4D34-93FA-287C88BE044CQ40249390-83543F56-7ECD-4C77-AD8F-05D989537A27Q40288437-574FEB52-0BEF-499B-8239-E16022BC26DDQ41194064-7A2FD689-9842-404C-BD8E-DF99607CDA59Q42334482-6A08BC61-5C6E-4A19-83A4-C47D26031DF7Q42983342-58ACDA1E-5994-4953-A057-E611B2E7B245Q42985626-32F8D08D-9CB0-49D5-AE03-23F4D75D126BQ43817442-306963A5-CB7F-4206-A31D-B97539190A0DQ45325556-6F557DAD-3A33-46B1-BA33-D6E7D500250FQ47901335-E12C0AE5-D530-42BF-A928-47A2DD2F7087Q64068510-3C8692E4-B3F1-40FE-9840-DEA5C1D77C6FQ64996324-A4B406E8-58CE-4694-A2D4-478B5DE11CBBQ91513422-CCDD6CA2-3AA8-492F-81FE-2E73CB14AE82Q91637698-2B7C16AC-219B-4C74-8470-E5771C14B035Q91766582-1C06A3D5-0B6B-4586-9F5A-01E42C30F9D8Q93037544-77D7E8B3-C711-4AC8-B923-58C4EF685F4F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giuseppe A. Sautto
@ast
Giuseppe A. Sautto
@en
Giuseppe A. Sautto
@es
Giuseppe A. Sautto
@nl
Giuseppe A. Sautto
@sl
type
label
Giuseppe A. Sautto
@ast
Giuseppe A. Sautto
@en
Giuseppe A. Sautto
@es
Giuseppe A. Sautto
@nl
Giuseppe A. Sautto
@sl
prefLabel
Giuseppe A. Sautto
@ast
Giuseppe A. Sautto
@en
Giuseppe A. Sautto
@es
Giuseppe A. Sautto
@nl
Giuseppe A. Sautto
@sl
P1053
A-8588-2015
P106
P1153
35307946400
P21
P2798
P31
P3829
P3835
giuseppe-sautto
P496
0000-0002-0273-2235